This application is for a three year project to clarify the role of serotonin (5-hydroxytryptamine [5-HT]) in suicidal behavior in adolescents. Serotonin system dysfunction may be related to suicidal behavior, so that abnormal levels of the serotonin metabolite 5-HIAA in cerebrospinal fluid (CSF) may be useful as a trait marker identifying those suicidal adolescents at risk for future attempts and even suicide completion. Two groups of inpatient adolescents (N=60) with major depressive disorder, ages 12-18 years, will be recruited to participate in an inpatient fluoxetine treatment program using standardized rating forms to assess depression, suicidal ideation and behavior. Thirty adolescents will make up a group of index """"""""attempters"""""""" (Group 1 because of their history of a suicide attempt during the previous 12 months; an additional 30 inpatients (Group 2) with major depressive disorder but no history of suicide attempt, and will make up the """"""""non-attempter"""""""" group. Groups 1 and 2 will begin the study with a psychiatric inpatient hospitalization, which will last approximately 4 weeks. They will have a baseline biological test battery consisting of a lumbar puncture and fenfluramine challenge tests. Thirty normal adolescents (Group 3), ages 12-18, with no history (or in first- and second-degree relatives) of depressive disorders and suicidal behavior, will be recruited as normal controls for the fenfluramine challenge and 5-HT(2) binding studies (but no lumbar punctures).
Specific Aim 1 is to test the hypothesis that the suicide attempter group (Group 1, N=30) has more """"""""blunted"""""""" prolactin responses to fenfluramine, and more 5-HT(2) binding sites (B(MAX)) than a diagnostic control group of depressed inpatient non-attempters (Group 2, N=30) and a group of normal adolescents (Group 3, N=30); in addition, for the inpatient adolescents only, that the suicide attempter group (Group 1) has significantly lower baseline levels of CSF 5-HIAA concentration than a group of depressed non-attempters;
Specific Aim 2 is to assess the relation between the study's biochemical measures of serotonergic function - CSF 5-HIAA, PRL responses to fenfluramine, and 5HT(2) binding - and measures of psychopathology, depression, suicidal behavior, impulsivity and aggression.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH047113-03
Application #
2247421
Study Section
Special Emphasis Panel (SRCM (03))
Project Start
1993-04-01
Project End
1996-03-31
Budget Start
1995-04-01
Budget End
1996-03-31
Support Year
3
Fiscal Year
1995
Total Cost
Indirect Cost
Name
New York State Psychiatric Institute
Department
Type
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Greenhill, L L; Waslick, B (1997) Management of suicidal behavior in children and adolescents. Psychiatr Clin North Am 20:641-66